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Cells lining the respiratory tract are equipped with mechanisms that dampen the effects of
oxidative stress. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a mediator involved in
regulating oxidative stress. Recent data indicate Nrf2 also controls expression of secretory
leukocyte protease inhibitor (SLPI). Sulforaphane (SFN), an isothiocyanate found in cruciferous
vegetables, enhances Nrf2 activity. Therefore, we hypothesized that SFN supplementation
induces SLPI secretion in the nasal mucosa in an Nrf2 dependent manner. Healthy nonsmoking
adults ingested SFN-containing broccoli shake homogenate (BSH) for 3 consecutive days. Nasal
lavage fluid (NLF) was collected before and after BSH ingestion and analyzed for SLPI protein
levels. In follow up in vitro experiments, differentiated primary nasal epithelial cells were
used to evaluate the relationship between SFN, Nrf2, and SLPI. Epithelial cells were trans-
duced with Nrf2-specific shRNA to examine the regulatory role of Nrf2 on SLPI expression.
Supplementation with BSH significantly increased SLPI levels in NLF. SFN supplementationof Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7310, USA.
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SLPI secretion in the nasal mucosa 473in vitro significantly enhanced SLPI secretion and these effects were significantly decreased in
cells transduced with Nrf2-specific shRNA.
Our data support a relationship between nutritional supplementation, Nrf2 activation, and
SLPI secretion. Therefore, ingestion of SFN-containing foods has therapeutic potential to
augment SLPI expression in the nasal mucosa.
ª 2012 Elsevier Ltd. All rights reserved.To combat and alleviate exogenous stressors, cells lining
the respiratory tract have evolved sophisticated sensing
and signaling pathways to dampen the effects of cellular
damage. The transcription factor nuclear factor (erythroid-
derived 2)-like 2 (Nrf2) plays a critical role in maintaining
respiratory homeostasis through the regulation of detoxi-
fying enzymes and antioxidants.1 Nrf2 has been shown to
protect against infection and ameliorates the development
of respiratory disorders such as COPD and asthma.2,3
Recent data indicate that Nrf2 also regulates expression
of an antiprotease, secretory leukocyte protease inhibitor
(SLPI), by binding to the antioxidant response element
(ARE) regions [GenBank AF205374] in the 1.2 kb promoter
region of the SLPI gene.3,4 SLPI is an 11.7 kDa heavily
disulfide bonded, positively charged protein found highly
expressed in epithelial cells at mucosal surfaces as well as
in inflammatory cells such as neutrophils and macrophages
and contributes to host defense by regulating unchecked
inflammation.5 Reduced levels of SLPI have been associated
with several different respiratory diseases, including
emphysema, COPD, and cystic fibrosis.5
Agents known to increase Nrf2 activation and Nrf2-
dependent gene expression include sulforaphane (SFN),
an isothiocyanate found in cruciferous vegetables. In the
context of the respiratory epithelium, SFN induces Nrf2
levels and exhibits protective effects in airway epithelial
cells via enhancing the expression of phase II enzymes.6
However, despite SFN induction of Nrf2-dependent genes,
its effect on the production and release of SLPI is not
known. As such, we hypothesize that ingestion of SFN-
containing foods has therapeutic potential to augment
SLPI expression and secretion in an Nrf2 dependent manner.
To test this hypothesis, we conducted an in vivo nutritional
supplementation study in a small cohort of healthy volun-
teers as well as in vitro experiments to determine if SFN or
SFN-containing foods induce SLPI secretion in the nasal
mucosa.
To test the impact of SFN-containing foods on SLPI
secretion in vivo, we enrolled 12 healthy volunteers (Age:
24.8  3.5; Sex: 6 Male, 6 Female; Race: 7 Caucasian, 4
African American, 1 Asian; BMI: 25.8  4.8) in a pilot clin-
ical nutritional supplementation study using a SFN-rich
broccoshake homogenate (BSH). Commercially available
Broccosprouts (Brassica Protection Products LLC) were
used in the study and BSH were prepared similar to
a previously described formula and supplementation
protocol, resulting in enhanced phase II enzyme expression
in the nasal mucosa.7 Briefly, 200 g Broccosprouts were
homogenized with 4.8 oz water and frozen at 20 C until
the morning of the ingestion protocol. Subjects were asked
to consume the entire BSH and to keep a food diary. To
assure that the SFN content did not change over time in
storage, we determined free SFN levels in BSH as previouslydescribed and found that BSH samples prepared on
two different days, separated by three months, revealed
similar free SFN levels, indicating batch to batch compati-
bility (May SFN level: 95.9 mmol/L; Aug SFN level:
118 mmol/L).8
The BSH supplementation study took place over four
consecutive days. Subjects were asked to avoid ingestion of
cruciferous vegetables for one week prior to and during the
study. Informed consent was obtained from all subjects and
the protocol was approved by the UNC Biomedical Institu-
tional Review Board. Baseline nasal lavage fluid (NLF) was
taken before the first of three daily ingestions of BSH.
Additional NLF samples were collected two hours post
ingestion of the second and third BSH dose as well as 24 h
after the last ingestion. We chose to collect NLF since it is
a non-invasive, easily accessible procedure used in previous
BSH supplementation studies.7 All NLF samples were ob-
tained and processed as previously described.9 Cell-free
NLF was analyzed for SLPI protein levels using commer-
cially available ELISA kits (R&D, Minneapolis, MN). Supple-
mentation of human volunteers with SFN-containing BSH
enhanced SLPI levels in NLF within 24 h and was statistically
significant after 48 h BSH ingestion (Fig. 1A). Additionally
we analyzed serum SLPI levels taken at baseline and 24 h
post last BSH ingestion, to test if SLPI levels in the NLF were
from exudate or transudate. We found a slight non-
statistically significant induction of SLPI serum levels
(data not shown). However, since serum was collected 24 h
post last BSH ingestion and considering the short half-life of
SFN,7 we are not able to determine if SLPI levels in the NLF
are from exudate or transudate.
To confirm and expand these in vivo observations, we
examined whether supplementation of nasal epithelial
cells (NEC) with SFN enhances production of SLPI. Human
differentiated NEC were treated with 10 mM SFN from the
basolateral side and analyzed for intracellular and
secreted SLPI levels 24 h post supplementation. Analysis of
whole cell lysates using Western blot indicated that SFN
exposure did not enhance intracellular SLPI levels (data
not shown). However, secreted SLPI protein levels
measured in the apical washes of differentiated NEC were
enhanced by SFN supplementation (Fig. 1B), corroborating
the in vivo data, which showed enhanced SLPI levels in the
NLF.
To further investigate the link between SFN supple-
mentation, Nrf2 activation, and nasal SLPI expression, we
used an in vitromodel similar to previous studies.2 Based on
these previous studies, we determined that a SFN concen-
tration of 10 mM is sufficient to distinguish differences in
Nrf2 dependent gene expression without causing cytotox-
icity.2 Specifically, to examine the effects of SFN supple-
mentation on the transcriptional regulation of SLPI, BEAS-
2B cells, a human bronchial epithelial cell line, were
Figure 1 SFN supplementation induces SLPI secretion in vivo and in vitro and is mediated by Nrf2. (A) Nasal lavage fluid obtained
from 12 healthy volunteers on days 1e3 after daily BSH ingestion was analyzed for SLPI protein levels. (B) Densitometric analysis of
SLPI expression in apical washes of NEC treated with SFN and normalized to levels in vehicle treated cells from n Z 5 different
subjects. Representative Western blot of SLPI levels in apical washes from NEC treated with vehicle (Veh) or SFN for 24 h (insert).
(C) BEAS-2B cells were transfected with SLPI-promoter reporter plasmid, exposed to 10 mM for 5 h, and evaluated for SLPI gene
transcription. SLPI-promoter reporter dependent luciferase activity was normalized to Renilla levels and expressed as relative
luciferase units (RLU). In some experiments, BEAS-2B were transduced with lentiviral vectors encoding Nrf2-specific shRNA (LV-
Nrf2) or scrambled vectors (LV-Scr) 48 h prior to transfection with SLPI-reporter plasmid and exposed to 10 mM for 5 h to evaluate
SLPI-promoter reporter dependent luciferase. *p < 0.05, **p < 0.01, ***p < 0.001.
474 M. Meyer et al.transfected with a SLPI promoter-reporter construct con-
taining 1385 base pairs of the 50 regulatory region of the
SLPI gene. Fig. 1C demonstrates that SFN supplementation
significantly increased SLPI gene transcriptional activation.
To evaluate if SFN induction of SLPI gene expression was
dependent on Nrf2, we transduced BEAS-2B cells with len-
tiviral vectors that expressed either Nrf2-specific shRNA
(LV-Nrf2) or scrambled vectors expressing a nonspecific
sequence for use as a control (LV-Scr) as previously
described.2 Transduced BEAS-2B cells were subsequently
transfected with the SLPI promoter-reporter and exposed
to 10 mM SFN for 5 h, demonstrating that reducing Nrf2
expression results in decreased SFN-induced SLPI expres-
sion (Fig. 1C), thus mechanistically linking SFN, Nrf2, and
SLPI expression.
Our study provides novel in vivo and in vitro evidence
linking nutritional SFN supplementation, Nrf2 activation,
and enhanced SLPI secretion in the nasal mucosa. SLPI
inhibits proteases such as cathespin G and neutrophil
elastase, which are both associated with tissue damage in
the context of chronic respiratory conditions like COPD and
asthma. In addition, we have recently demonstrated that
SLPI protects against influenza A virus (IAV) infection in
nasal epithelial cells and that supplementation with SFN
protects against IAV entry.2,10 Since susceptibility to respi-
ratory virus infection, including IAV, is enhanced in subjects
with COPD and asthma, our data suggest a potential role for
nutritional supplementation to improve respiratory defenseand homeostasis in these subpopulations via changes in the
protease/antiprotease balance, which is an ongoing focus
of our research.
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